Cost-effectiveness projections of FOLFOX vs. IFL in first-line therapy of metastatic colorecial cancer in the context of the US health care system.

作者： BE Hillner , D Schrag , DJ Sargent , CS Fuchs , RM Goldberg

DOI:

关键词: